Containing Or Obtained From Panax Or Acanthopanax (e.g., Ginseng, Etc.) Patents (Class 424/728)
-
Publication number: 20120189660Abstract: The present invention relates to a composition for preventing or treating liver diseases, which contains, as an active ingredient, any one or more of a homogeneous cell line derived from the cambium of Panax ginseng, including wild ginseng or ginseng, a lysate thereof, an extract thereof and a culture medium thereof. The homogeneous cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof have minimized side effects compared to existing agents for treating liver diseases, and thus are safe for the human body. Also, they can increase the levels of s-antibody (HBsAb) and e-antibody (HBeAb) against hepatitis virus and inhibit the proliferation of hepatitis virus, and thus they are useful for the prevention and treatment of liver diseases. In addition, they have the effect of lowering the levels of liver injury, and thus are useful as a functional food for improving liver function.Type: ApplicationFiled: August 14, 2009Publication date: July 26, 2012Inventors: Young Woo Jin, Eun Kyong Lee, Min Jung Lim
-
Patent number: 8221804Abstract: The invention encompasses novel compositions containing a methylation modifying compound isolated from botanical raw materials, including a fruit of the genus Coffea, and microbial raw materials, methods of making such compositions, and methods of treating or preventing human disease using such compositions. The methylation modifying compound in botanical extracts of the present invention can dramatically increase the level of methylation of PP2A, thus increasing cognitive function, particularly in persons suffering from or prone to developing Alzheimer's disease.Type: GrantFiled: February 3, 2006Date of Patent: July 17, 2012Assignees: Signum Biosciences, Inc., Trustees of Princeton UniversityInventors: Jeffry B. Stock, Maxwell Stock, Haoming Gu, Gregory B Stock, Zhu Li, Peter Michael Wolanin
-
Publication number: 20120156272Abstract: The invention is related to a composition comprising vegetable extract, carbohydrate and phospholipid for cosmetic, pharmaceutical or dietary application.Type: ApplicationFiled: February 24, 2012Publication date: June 21, 2012Applicant: Lipoid GmbHInventor: Herbert REBMANN
-
Patent number: 8202550Abstract: Pharmaceutical compositions are for administration to the nasal tract. In particular, dry powder compositions are cellulose, and in particular hydroxypropylmethylcellulose (HPMC), and one or more therapeutic agents. It has been shown that administration of HPMC to the nasal cavity is capable of enhancing natural mucus. These powders, and the gel that forms when they are administered to the nasal tract, have now surprisingly been found to be a very effective way of intranasally administering therapeutic agents, and in particular, herbal or homeopathic agents.Type: GrantFiled: October 10, 2005Date of Patent: June 19, 2012Assignee: Nasaleze PPM LimitedInventors: Michael James, Peter Josling
-
Publication number: 20120148686Abstract: Disclosed is a method capable of improving the skin regeneration effect of medicinal materials through double boiling using an earthenware pot. The method shows an excellent skin regeneration effect, and the extract of medicinal materials obtained therethrough can be variously applied in the fields of cosmetics, health foods or medicine.Type: ApplicationFiled: August 18, 2010Publication date: June 14, 2012Inventors: Dong Hyun Kim, Jun Seong Park, Hui Kyeung Chang, Duck Hee Kim, Han Kon Kim
-
Publication number: 20120148685Abstract: The present invention relates to compositions comprising (i) an activator of transport of fatty acids into the mitochondria; (ii) an activator of fatty acid oxidation; and (iii) an inhibitor of fatty acid biosynthesis, and methods for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome, dyslipidemias, obesity, and/or cardiovascular disorders in a subject.Type: ApplicationFiled: June 10, 2010Publication date: June 14, 2012Applicant: Engergy4Life AGInventor: Markus Rohner
-
Patent number: 8197866Abstract: A herbal treatment for Diabetes Mellitus, Type II comprises a first volume of herbal oils and a first weight of ground herbs. The mixture of the oil and ground herbs forms a paste, which is dispensed in a gel capsule.Type: GrantFiled: March 19, 2009Date of Patent: June 12, 2012Inventor: Maria Lukacs
-
Publication number: 20120141613Abstract: Disclosed is a composition containing an active ingredient or ingredients comprising an extract or extracts of one or more constituents selected from the group consisting of Astragalus membranaceus, Saururus chinensis, Glycyrrhizae radix, rose, rhubarb, Acanthopanax senticosus and cortex Phellodendri. The composition is efficacious in suppressing acneiform pigment deposition and/or pitted scars, and can be used to advantage in various ways in the fields of cosmetics, foods and drugs.Type: ApplicationFiled: August 13, 2010Publication date: June 7, 2012Applicant: Amorepacific CorporationInventors: Jeong-Hwan Kim, Won Seok Park, Hyun Ju Koh, Hong-Ju Shin, Do-Hoon Kim, Jong Hee Park, Chang-Geun Yi, Hyoung Jun Kim, Jung A . Seo
-
Publication number: 20120135093Abstract: The present invention discloses a soap composition containing a ginseng absolute oil, based on the finding that a ginseng extract, particularly a ginseng absolute oil, has a potent effect on the treatment of acne. A soap composition for treating acne according to one embodiment of the present invention was used, and as a result, it could be seen that the soap composition exhibited excellent effects of removing sebum and killing acne bacteria to prevent proliferation of the bacteria and infection with the bacteria, thus exhibiting a potent effect on the treatment of acne.Type: ApplicationFiled: July 14, 2009Publication date: May 31, 2012Applicant: SOONCHUNHYAND UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATIONInventors: Sang Kil Han, Joo Yang Mang
-
Patent number: 8182845Abstract: The objectives are to find a substance or a composition capable of promoting the production of ghrelin with physiological activities such as growth hormone secretion effect, and to provide a pharmaceutical comprising it as the active ingredient. The pharmaceutical is a ghrelin production promoter comprising Rikkunshi-to as the active ingredient.Type: GrantFiled: September 7, 2010Date of Patent: May 22, 2012Assignees: National University Corporation Hokkaido University, Tsumura & Co.Inventors: Masahiro Asaka, Hiroshi Takeda, Ryuuji Takasaki, Tomohisa Hattori
-
Publication number: 20120121734Abstract: Novel utilization of sucralose which is a high intense sweetener. Compositions containing sucralose including: sweetening compositions having excellent sweetness qualities based on the characteristics of sucralose; foods with a masked unpleasant smell and unpleasant taste; performance food compositions (viscous food compositions, gel food compositions, emulsified food compositions); foods with improved flavors; preservatives and foods with improved quality of taste; and flavor compositions with improved flavors. Novel utilization of sucralose as a sweetener improver, a masking agent for unpleasant smell/unpleasant taste, a flavor improver, a function improver (viscosity, gelling properties, emulsification properties), a taste characteristic improver, and a flavor improver/enhancer.Type: ApplicationFiled: January 19, 2012Publication date: May 17, 2012Applicant: SAN-EI GEN F.F.I., INC.Inventors: Maki Inoue, Kazumi Iwai, Naoto Ojima, Takuya Kawai, Mitsumi Kawamoto, Shunsuke Kuribi, Miho Sakaguchi, Chie Sasaki, Kazuhito Shizu, Mariko Shiguryou, Kazutaka Hirao, Miki Fujii, Yoshito Morita, Nobuharu Yasunami, Junko Yoshifuji
-
Publication number: 20120121735Abstract: The present invention features compositions and methods for suppressing appetite. The compositions of the invention are composed of a dietary fiber and a combination of selected herbal extracts, at least one of which is capable of inhibiting gastric emptying and one which increases metabolic rate.Type: ApplicationFiled: June 28, 2010Publication date: May 17, 2012Applicant: Natures Remedies Ltd.Inventors: Jason C. G. Halford, Trevor R. Jarman
-
Publication number: 20120121621Abstract: The invention relates to synergistic compositions comprising prebiotic components selected from fructose polymers GFn and Fm, either containing a glucose (G) end-group, or without a glucose end-group, and one or more component of a group of prebiotics consisting of modified or unmodified starch and partial hydrolysates thereof, partially hydrolysed inulin, natural oligofractoses, fructo-oligosaccharides (FOS), lactulose, galactomannan and suitable partial hydrolysates thereof, indigestible polydextrose, acemannan, various gums, indigestible dextrin and partial hydrolysates thereof, trans-galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), beta-glucan and partial hydrolysates thereof, together if desired with phytosterol/phytostanol components and their suitable esters, and if desired other plant extracts, mineral components, vitamins and additives.Type: ApplicationFiled: January 19, 2012Publication date: May 17, 2012Inventors: Csaba József Jászberényi, Tamás János Szakács
-
Patent number: 8173181Abstract: Nutritional compositions are provided containing at least one PPAR agonist, at least one PGC-1alpha agonist, and at least one creatine derivative. Methods of promoting anabolism and improving or enhancing physical performance using the compositions are provided. The compositions and methods can be combined with physical training or exercise.Type: GrantFiled: November 9, 2010Date of Patent: May 8, 2012Assignee: Bio-Engineered Supplements & Nutrition, Inc.Inventors: Chris Ferguson, Sal Abraham
-
Publication number: 20120107426Abstract: The objectives are to find a substance or a composition capable of promoting the production of ghrelin with physiological activities such as growth hormone secretion effect, and to provide a pharmaceutical comprising it as the active ingredient. The pharmaceutical is a ghrelin production promoter comprising Rikkunshi-to as the active ingredient.Type: ApplicationFiled: January 9, 2012Publication date: May 3, 2012Applicants: TSUMURA & CO., NAT. UNI. CORP. HOKKAIDO UNIVERSITYInventors: Masahiro ASAKA, Hiroshi Takeda, Ryuuji Takasaki, Tomohisa Hattori
-
Publication number: 20120107300Abstract: Cannabinoid compositions and methods of administering said cannabinoid compositions are disclosed. The cannabinoid compositions disclosed herein include compounds which have been strategically selected to eliminate, or least mitigate, one of the negative side effects associated with consuming cannabinoids. A daytime formula includes compounds aimed at nullifying the negative side effects that cannabinoid consumption has on a patient's daily operations and activities. A nighttime formula includes compounds aimed at nullifying the negative side effects that cannabinoid consumption has a patient's sleep.Type: ApplicationFiled: November 1, 2010Publication date: May 3, 2012Inventor: Jeffrey Nathan Schirripa
-
Publication number: 20120107427Abstract: Disclosed is a composition containing an active ingredient comprising one or more extracts selected from the group consisting of Rehmannia glutinosa, licorice, Coix lacryma-jobi seed, wheat germ, Chaenomeles sinensis fruit, Acanthopanacis cortex and Radix puerariae. The composition promotes adipocyte differentiation and fat globule production, and is effective in reducing skin wrinkles, increasing skin elasticity and preventing skin ageing.Type: ApplicationFiled: June 30, 2010Publication date: May 3, 2012Applicant: Amorepacific CorporationInventors: Ji Seong Kim, Ga Young Cho, Eun Joo Kim, Jun Seong Park, Ho Sik Rho, Hye Yoon Park, Duck Hee Kim, Han Kon Kim
-
Patent number: 8168239Abstract: Disclosed is a method for the production of a diet food with medicinal herbs. According to the method, herbs which have physiological activities suitable for dieting are selected by making reference to various reports and through experimentation. Depending on nutritional and pharmaceutical ingredients responsible for the physiological functions and activities, the herbs are classified into three groups, and combined with each other to form a composition which is extracted in such a manner that as few effective ingredients are lost as possible. The diet food is effective for the prevention and treatment of obesity.Type: GrantFiled: May 27, 2011Date of Patent: May 1, 2012Inventor: Se Kyu Im
-
Publication number: 20120076875Abstract: A herbal medicinal composition and an extract thereof for inducing proliferation of cranial nerve cells and a method of manufacturing the same are disclosed. The herbal medicinal composition includes Ginseng Radix and Aconiti Tuber.Type: ApplicationFiled: January 4, 2011Publication date: March 29, 2012Applicant: Chen-Yu LEEInventors: Chen-Yu Lee, Hsiu-Chin Ho, Cheng-Fu Chang, Yi Lin Chen
-
Patent number: 8137712Abstract: The present invention relates to a composition for the relief of hangover symptoms and methods of treating hangover symptoms.Type: GrantFiled: August 8, 2007Date of Patent: March 20, 2012Inventor: Evan Hays
-
Publication number: 20120064182Abstract: A cosmetic or dermatological preparation that is obtainable by combining collagen and/or a derivative thereof, chitosan and/or a derivative thereof, glycosylaminoglycan and/or a derivative thereof with a peptide which is capable of promoting skin cell growth and/or with a composition which comprises glycoproteins 1 and 2 and ginseng and horsetail extracts.Type: ApplicationFiled: February 1, 2010Publication date: March 15, 2012Applicant: BEIERSDORF AGInventors: Sven Gohla, Daniel Stangl
-
Publication number: 20120052103Abstract: The present invention relates to a cosmetic composition containing white ginseng powder. Applying a cosmetics containing white ginseng powder to the skin of a user stimulates blood circulation and exhibits superior skin scrubbing effect.Type: ApplicationFiled: April 20, 2010Publication date: March 1, 2012Inventors: Sunsang Kwon, Go Un Han, Eun Joo Kim, Duck Hee Kim, Han-kon Kim
-
Publication number: 20120039928Abstract: The present invention relates to an extract of a processed herbal medicinal plant and a composition for skin external application which contains the extract. More specifically, the composition for skin external application contains an extract of processed herbal medicinal plant, prepared through a method comprising the steps of: (a) processing an herbal medicinal plant by a process of boiling, steaming, roasting, baking or heating the medicinal plant or a combination of two or more of these processes; (b) obtaining an extract of the processed medicinal plant. The composition shows an improved antioxidant effect.Type: ApplicationFiled: October 18, 2011Publication date: February 16, 2012Inventors: Jun Seong Park, Hye Yoon Park, Dong Hyun Kim, Eun Jeong Moon, Ji Hye Chung, Jae Kyoung Lee, Duck Hee Kim, Han Kon Kim
-
Publication number: 20120040030Abstract: A nasal solution and method for treating nasal and sinus inflammation. The nasal solution includes vitamin C, an extract of scutellaria radix, an extract of eleutherococcus radix, an extract of chamomile, and a pharmaceutically acceptable carrier which is suitable for administering the vitamin C, the scutellaria radix extract; the eleutherococcus radix extract; and the chamomile to the nose of a patient. The method includes administering the nasal solution which suppresses early phase and late phase mediators of allergic mucosal disease in order to maintain long-term inhibition of nasal and sinus inflammation.Type: ApplicationFiled: December 30, 2009Publication date: February 16, 2012Applicant: BZMI, LLCInventors: S. James Zinreich, Claus Bachert
-
Publication number: 20120034323Abstract: The present invention relates to compositions comprising plants and extracts of plants with chlorogenic acids and antioxidants and/or caffeine; methods for preparing the same; and methods to promote weight loss through the administration of compositions containing these plants and plant extracts in specific proportions.Type: ApplicationFiled: August 3, 2010Publication date: February 9, 2012Applicant: NORTHERN INNOVATIONS AND FORMULATIONS CORP.Inventors: John Doherty, Phil Apong, James Akrong, Shawn Shirazi
-
Patent number: 8110230Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: GrantFiled: February 12, 2010Date of Patent: February 7, 2012Inventor: Jose Angel Olalde Rangel
-
Publication number: 20120015056Abstract: The present invention relates to an extract or fraction of Cinnamomum aromaticum, Arctium lappa, Viticis fructus, Lonicera japonica, Acanthopanax gracilistylis, Raphanus sativus, Astragalus membranaceus and Hordeum vulgare, and a composition comprising said extract or fraction. The invention also relates to the use of said composition for treating or preventing cancers, preventing loss of hair, and stimulating hair growth. The invention also relates to a process for preparing said composition.Type: ApplicationFiled: July 29, 2010Publication date: January 19, 2012Inventor: Gee-Hwoon LEE
-
Publication number: 20120015021Abstract: Compositions for appetite suppression and methods of making and using thereof are disclosed herein. The compositions are typically in the form of a tablet, such as a single or multi-layer sticker tablet. The compositions adhere to a buccal surface or mucosal surface in the oral cavity for at least 15 minutes, preferably for at least 30 minutes. In a preferred embodiment, the compositions contain herbal agents that are anti-appetite agents. The composition is generally effective for suppressing appetite for a time period ranging from at least 30 minutes up to eight hours following administration to the buccal or oral mucosa.Type: ApplicationFiled: July 13, 2010Publication date: January 19, 2012Inventors: Boaz Mizrahi, Benny Brama, Abraham J. Domb
-
Publication number: 20120003316Abstract: This invention relates to a multi-configured, transmucosal pharmaceutical dosage form and, more particularly, to a pharmaceutical dosage form which has a single monolithic/heterogeneous layer or a plurality of such layers. The dosage form is suitable for the delivery of one or more pharmaceutical compositions via the buccal, sublingual, rectal, vaginal or transmucosal delivery route in a human or animal body. It provides for selected delivery profiles resulting from, but not limited to, a porosity-enabled composite matrix of one or more layers/components of the pharmaceutical composition/s. The invention also provides for a method of manufacturing said transmucosal pharmaceutical dosage form in a plurality of configurations.Type: ApplicationFiled: June 3, 2009Publication date: January 5, 2012Inventors: Deshika Reddy, Oluwatoyin Ayotomilola Adeleke, Viness Pillay, Yahya Choonara
-
Patent number: 8071844Abstract: A plant grown from seeds derived from a new interhybrid of three plants of the Momordica genus has been cultivated. The new plant hybrid has a faster growth rate than the parent species. Parts of the new interhybrid plant which, when ingested by an individual, have blood glucose and/or insulin regulating properties. Foods and/or beverages containing parts or extracts of the new interhybrid plant and which to promote weight control or loss and/or blood glucose regulation are also disclosed.Type: GrantFiled: September 15, 2008Date of Patent: December 6, 2011Assignee: Nutritional Health Institute Laboratories, LLCInventors: William F. Huggins, Konky Sotomayor
-
Publication number: 20110293754Abstract: The present invention relates to the anticancer composition containing an effective amount of herbal extract, and more particularly to the anticancer composition containing an effective amount of extract of Salviae Miltiorrhizae Radix, Chrysanthemum indicum, Acanthopanax senticosus, Cinnamomum cassia Blume, Eucommia ulmoides Oliv., Glycyrrhiza uralensis Fisch, Pueraria thunbergiana Benth, Crataegus pinnatifida Bunge, Cassia tora, Carthamus tinctorius L., Paeonia lactiflora Pall, and Angelica gigas Nakai. The anticancer composition containing an effective amount of herbal extract has advantage of minimal or few side effects and cytotoxicity as compared to many existing anticancer drugs having cytotoxicity and side effects.Type: ApplicationFiled: May 28, 2010Publication date: December 1, 2011Applicant: DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATIONInventors: Jai-Heon Lee, Kyoung-Sook Kim, Young-Choon Lee, Chang-Woo Cho, KyoungMee Kim, Young Soo Chung
-
Patent number: 8062680Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: GrantFiled: February 12, 2010Date of Patent: November 22, 2011Inventor: Jose Angel Olalde Rangel
-
Publication number: 20110280852Abstract: A composition for treating, ameleliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death comprise a fatty acid component enriched for one or more activated fatty acids and a nutraceutically acceptable excipient. A method for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death includes administering a fatty acid component enriched for one or more activated fatty acids.Type: ApplicationFiled: May 13, 2011Publication date: November 17, 2011Applicant: NITROMEGA CORP.Inventor: Raymond A. Miller
-
Publication number: 20110274707Abstract: The present invention relates to a composition for improving inflammatory disease, and more specifically to a composition for improving inflammatory disease able to improve inflammatory reactions and the barrier function of epithelial tissue such as the skin, to enhance aging resistance and skin elasticity and to prevent or treat aging.Type: ApplicationFiled: January 7, 2010Publication date: November 10, 2011Applicant: SNU R&DB FOUNDATIONInventors: Jang Hee Oh, Ji-Yong Jung, Dong Hun Lee, Serah Lee, Yeon Kyung Kim, Jeong-eun Shin, June Hyunkyung Lee, Jin Ho Chung
-
Publication number: 20110274774Abstract: Methods of defining a standard for a traditional medicine are provided. A method can comprise obtaining at least two samples of the traditional medicine that have been authenticated by qualitative profiling as representing a control positive; quantitatively profiling each of the at least two samples using at least two physicochemical analyses; blending the at least two samples to form the standard; and creating a quantitative profile for the standard using at least two physicochemical analyses, wherein the quantitative profile for the standard defines the standard. Methods of certifying a test sample of a traditional medicine are also provided. A method can comprise creating a quantitative profile for the test sample using at least two physicochemical analyses; providing a standard; and comparing the quantitative profile for the standard to the quantitative profile for the test sample. A certified traditional medicine comprises a traditional medicine certified by these methods.Type: ApplicationFiled: April 1, 2011Publication date: November 10, 2011Applicant: PHYTO-TRUE, LLCInventor: Albert Y. Leung
-
Publication number: 20110274773Abstract: A method for preparation pharmaceutical compounds in large quantities consists of copper (I) halide, preferably the chloride complex of nicotinic acid characterized by elemental analysis, spectroscopy and crystallographic methods, used for treatment of muscular dystrophy, myopathy, myasthenia gravis, parkinsonism, Chronic Fatigue Syndrome, Male Infertility and post stroke muscle weakness. Chlorobis (nicotinic acid) copper (I) monohydrate complex, its composition [CuCl (nicotinic acid)2]. H2O, has been prepared and its physical and chemical properties as well as its crystal structure have been investigated for the first time.Type: ApplicationFiled: January 28, 2011Publication date: November 10, 2011Inventor: Salah Fathiy Hussein Aly Ibraheim
-
Patent number: 8053004Abstract: A composition and method of use therefore that provides for the objective topical treatment of hot flashes that is clinically shown to objectively reduce skin temperature, with the effective ingredients including menthol and peppermint oil which can be substituted with spearmint oil. The method involves application of the composition, which can be in the form of a liquid, crème, topical gel, mist or moist towelette and which is applied most optimally to the back of the neck, the front of the neck, behind the ears and on the wrists of the sufferer.Type: GrantFiled: April 1, 2008Date of Patent: November 8, 2011Assignee: Starmaker Products, LLCInventors: Anson Williams, Joanna Connell
-
Publication number: 20110268824Abstract: A composition according to the present invention is a composition containing extract of Panax ginseng C.A. Meyer fruit as an active ingredient for preventing or treating artherosclerosis. The extract is confirmed to effectively suppress lesions or generation of a vascular inflammation factor caused by artherosclerosis. Thus, the composition is suitable for use as an active ingredient of the composition for preventing or treating artherosclerosis.Type: ApplicationFiled: November 26, 2009Publication date: November 3, 2011Applicant: AMOREPACIFIC CORPORATIONInventors: Chan-Woong Park, Dae Bang Seo, Hee Young Jeon, Sang Min Lee, Wan Gi Kim, Sang Jun Lee, Young-Myeong Kim, Chun-ki Kim
-
Publication number: 20110268823Abstract: The present invention provides a method for preparing an extract fraction reinforced with ginsenoside Rg1 or Rb1 from ginseng. The method for preparing an extract fraction reinforced with ginsenoside Rg1 comprises the steps of: concentrating an alcohol extract of ginseng and then adsorbing the extract diluted in water by adding the extract to an adsorption resin; passing distilled water through the adsorption resin, then eluting and removing unadsorbed ingredients; and adding 30 to 40 v/v % alcohol to the adsorption resin to obtain an eluate. The method for preparing an extract fraction reinforced with ginsenoside Rb1 comprises the steps of: concentrating an alcohol extract of ginseng and then adsorbing the extract diluted in water by adding the extract to an adsorption resin; passing distilled water through the adsorption resin, then eluting and removing unadsorbed ingredients; and adding 50 to 80 v/v % alcohol to the adsorption resin and then eluting.Type: ApplicationFiled: October 30, 2009Publication date: November 3, 2011Inventors: Yeong-Eun Kim, Doo-Kyung Kim, Yong-Ki Seo, Jin-Hee Lee
-
Publication number: 20110262568Abstract: Disclosed are a pharmaceutical composition useful for treating lumbar disc herniation and a method for the preparation thereof. Composed of herbal ingredients, the pharmaceutical composition neither incurs resistance nor side effects, even when it is administered for a long term. The composition comprises Acanthopanax senticosus in an amount of 20˜40 wt %, Atractylodis Rhizoma Alba in an amount of 30˜50 wt %, Carthamus tinctorius seed powder in an amount of 3˜10 wt %, Sophora flavescens Aiton in an amount of 5˜15 wt %, Achyranthis Bidentatae Radix in an amount of 1˜5 wt %, Dipsaci Radix in an amount of 1˜5 wt %, pine knars in an amount of 1˜5 wt %, Epimedium Koreanum in an amount of 1˜5 wt %, and Allium tuberosum in an amount of 1˜5 wt %.Type: ApplicationFiled: April 21, 2011Publication date: October 27, 2011Inventor: Kyoung Sam BYUN
-
Publication number: 20110256247Abstract: Activated fatty acids, topical compositions including activated fatty acids and methods for using activated fatty acids to treat a variety of diseases.Type: ApplicationFiled: June 30, 2011Publication date: October 20, 2011Applicant: NITROMEGA CORP.Inventor: Raymond A. Miller
-
Publication number: 20110250183Abstract: The present invention provides compositions and methods for treating stroke patients using TCM and a Western medicament used for the treatment of stroke patients.Type: ApplicationFiled: November 10, 2009Publication date: October 13, 2011Applicant: MOLEAC PTE. LTD.Inventors: David Picard, Shi Xuemin, Michael Lazdunski
-
Publication number: 20110236358Abstract: A composition comprising at least one isoflavone, phloridzin and one or more probiotics. A composition as described herein is also provided for internal use as a natural alternative to hormone replacement therapy and for treating disorders such as menopause and correlated symptoms, alcoholism, stress, insomnia, obesity and cellulite.Type: ApplicationFiled: December 10, 2009Publication date: September 29, 2011Inventor: Stefano Sala
-
Publication number: 20110229443Abstract: The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Panax ginseng cambium-derived cell line including wild ginseng or ginseng; a lysate thereof; an extract thereof; or a culture medium thereof. The cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof are derived from a natural and have minimized side effects compared to the conventional therapeutic drugs, and thus are safe for the human body. Also, they are involved directly in the growth of cancer to induce cancer cell death effectively, and show anticancer activity of inhibiting or reducing the formation of tumor or the growth of tumor, Accordingly, the cell line, the lysate thereof, the extract thereof and the culture medium thereof are useful for the prevention, treatment and alleviation of cancer.Type: ApplicationFiled: November 6, 2009Publication date: September 22, 2011Applicant: Unhwa CorporationInventors: Young Woo Jin, Eun Kyong Lee
-
Publication number: 20110230816Abstract: The present disclosure provides hydrogels that are suitable for drug delivery. In embodiments, hydrogels of the present disclosure may be used for transdermal delivery of bioactive agents, including drugs. The hydrogels of the present disclosure may also be useful as conductive compositions for use with electrodes.Type: ApplicationFiled: August 31, 2010Publication date: September 22, 2011Applicant: TYCO HEALTHCARE GROUP LPInventor: Warren Copp-Howland
-
Patent number: 8017147Abstract: A synergistic mixture (which may be utilized as a food or a drink or a supplement or a drug or a cosmetic or a hygienic product) that is formulated and is capable of improving a person's well being, lowering the risks of cardiovascular and/or Alzheimer's diseases and/or lowering blood sugar using natural and synthetic ingredients. Numerous ratios may be formulated for aroma, color, flavor, flow (viscosity), taste and uniformity. Moreover, ingredients for sugar substitutes, natural preservatives, nano-dispersion, nano-emulsion, nano-encapsulation of ingredients and apparatus for personalized nutrition are also described herein.Type: GrantFiled: October 2, 2009Date of Patent: September 13, 2011Inventors: Mohammad A. Mazed, Sayeeda Mazed
-
Publication number: 20110217273Abstract: The present invention relates to a composition for preventing or treating acquired immunodeficiency syndrome (AIDS), comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof, which are derived from a natural product, minimize adverse side effects of prior therapeutic agents and safe for the human body. Further, they effectively increase the count of T cells such as CD4+ T cells and decrease the number of HIVs, thereby preventing opportunistic infection, dysneuria, and neoplasia caused by immune incompetence, and ultimately the risk of death. Therefore, they are useful in preventing and treating AIDS, and relieving symptoms of AIDS.Type: ApplicationFiled: September 30, 2009Publication date: September 8, 2011Applicant: Unhwa CorporationInventors: Sun Mi Hong, Eun Kyong Lee, Young Woo Jin
-
Publication number: 20110212191Abstract: A composition is disclosed which comprises cinnamon or cinnamon extract such as cinnamon aqueous extract TC 112 and panax ginseng or extract from panax ginseng standardized to 1.5 to 7% ginsenosides and may comprise an artificial sweetener. The composition is embodied in the form of a pill or food product with 120 mg of cinnamon aqueous extract and 120 mg of ginseng standardized to 1 5 to 7% ginsenosides. The composition is used as a daily dosage for improvement of cognitive function, prevention or treatment of Alzheimer's disease, maintenance or lowering of blood-sugar levels, prevention of arterial disease or the improvement of cognitive function in diabetics.Type: ApplicationFiled: October 23, 2009Publication date: September 1, 2011Applicant: ALLEGIANCE EQUITY CORPORATIONInventors: David Solomon, Hector J. Gomez
-
Publication number: 20110212192Abstract: A composition of ingestible ingredients containing a first ingestible ingredient which has an undesired effect on the human body when ingested, wherein preferably the ingredient is sugar and the undesired effect is blood sugar fluctuations which can lead to diabetes, and at least one other ingestible ingredient which reduces the impact or the undesired effect of the first ingestible ingredient, wherein the other ingredient is either cinnamon or polyphenols from cinnamon, or ginseng or ginsenosides from ginseng. The composition may be in a package, a bulk mix or a product.Type: ApplicationFiled: October 23, 2009Publication date: September 1, 2011Applicant: ALLEGIANCE EQUITY CORPORATIONInventors: David Solomon, Hector J. Gomez
-
Publication number: 20110206722Abstract: A pharmaceutical composition includes Folium Isatidis 10-30 parts, Semen Cassiae 15-35 parts, Flos Inulae 10-20 parts, Flos Carthami 15-30 parts, Flos Chrysanthemi 10-30 parts, Herba Apocyni Veneti 20-50 parts, Ginkgo flavone 20-40 parts, emodin 20-35 parts, crataegin 30-50 parts, gypenoside 15-55 parts, Panax Notoginsenoside 20-60 parts. This composition can improve the level of high density lipoprotein in blood, clean up blockage of vein, soften vein, and reduce viscosity of blood.Type: ApplicationFiled: November 28, 2008Publication date: August 25, 2011Inventors: Zhizheng Du, Jiankui Tang